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ABSTRACT
Introduction COVID-19 has unprecedented consequences 
on population health, with governments worldwide issuing 
stringent public health directives. In the absence of a 
vaccine, a key way to control the pandemic is through 
behavioural change: people adhering to transmission- 
reducing behaviours (TRBs), such as physical distancing, 
hand washing and wearing face covering. Non- adherence 
may be explained by theories of how people think about 
the illness (the common- sense model of self- regulation) 
and/or how they think about the TRBs (social cognition 
theory and protection motivation theory). In addition, 
outbreaks of infectious diseases and the measures 
employed to curb them are likely to have detrimental 
effects on people’s mental and general health. Therefore, 
in representative repeated surveys, we will apply 
behavioural theories to model adherence to TRBs and 
the effects on mental and general health in the Scottish 
population from June to November 2020, following the 
initial outbreak of COVID-19.
Methods and analysis Repeated 20 min structured 
telephone surveys will be conducted with nationally 
representative random samples of 500 adults in Scotland. 
The first 6 weeks the survey will be conducted weekly, 
thereafter fortnightly, for a total of 14 waves (total 
n=7000). Ipsos MORI will recruit participants through 
random digit dialling. The core survey will measure 
the primary outcomes of adherence to TRBs, mental 
and general health, and explanatory variables from the 
theories. Further questions will be added, enabling more 
detailed measurement of constructs in the core survey, 
additional themes and questions that align with the 
evolving pandemic.
Ethics and dissemination Ethical approval for this study 
was granted by the Life Sciences and Medicine College 
Ethics Review Board (CERB) at the University of Aberdeen 
(CERB/2020/5/1942). Results will be made available to 
policy makers, funders, interested lay people and other 
researchers through weekly reports and three bimonthly 
bulletins placed on the CHARIS website and advertised 
through social media.
BACKGROUND
In December 2019, a new coronavirus 
(SARS- CoV-2) emerged, leading to a 
pandemic of an acute respiratory syndrome 
(COVID-19) in humans.1 The impact of the 
Strengths and limitations of this study
 ► The CHARIS study will provide insights into the link 
between (changes in) adherence to transmission- 
reducing behaviours and explanatory factors, and 
their effects on mental and general health, including 
event- related changes (eg, when government direc-
tives change).
 ► CHARIS will provide fast, real- time, information in a 
representative sample, making the findings gener-
alisable to the Scottish population, to support and 
inform decision making for policy- makers, public 
health and service commissioners.
 ► CHARIS is underpinned by evidence- based psycho-
logical theories, therefore, our study can draw on a 
large existing evidence base that informs the mea-
sures used, and details how individual constructs 
are meaningfully related.
 ► The primary limitation of this study is the use of a 
limited set of self- report measures that would open 
to a number of sources of error, including memory 
errors and social desirability bias.
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pandemic on European countries has been highly vari-
able, and the UK has one of the highest case and death 
rates from COVID-19 in Europe.2
As in previous outbreaks of infectious disease (eg, SARS, 
H1N1 influenza),3–5 stringent public health measures 
were implemented to curtail the spread of SARS- CoV-2.6 
However, in the current pandemic, social isolation 
measures were applied to whole populations rather than 
limited to those who are known to have been in contact 
with the virus. This is an unprecedented response by indi-
vidual governments and the international community.
Until a vaccine against coronavirus or an effective 
treatment for COVID-19 becomes available, adherence 
to transmission- reducing behaviours (TRBs) is crucial 
to protect lives and halt, or at least slow, transmission. 
Therefore, understanding the factors that determine 
adherence to TRBs is essential. While TRBs lessen both 
personal risk of acquiring COVID-19 and population level 
rates of COVID-19, they may have detrimental impacts on 
people’s health, especially their mental health.7–9 Further, 
the impact of the COVID-19 pandemic on mental 
health may vary between groups in the general popula-
tion due to pre- existing differences, including stresses 
of living in areas of high deprivation with low income, 
less secure housing and related effects.10 Moreover, the 
impact of COVID-19 may also be more pronounced for 
people with long- term conditions requiring supported 
self- management,11 or people who are self- isolating 
(shielding) for instance due to older age.12 Thus, our 
understanding of adherence to TRBs requires concom-
itant study of mental and general health to enable the 
investigation of the relationship between them and the 
impact of the pandemic on health more broadly.
TRANSMISSION-REDUCING BEHAVIOURS
Health policy, including guidelines on TRBs, is the remit 
of each devolved nation within the UK. The Scottish 
Government required the population to adopt strict phys-
ical distancing (including staying at home and only going 
out for a very few specific reasons, such food, medicine, 
work or exercise and always staying at least 2 m from other 
people), thorough hand hygiene measures and latterly 
recommended the wearing of face coverings when shop-
ping for food or using public transport (for the Scottish 
roadmap out of the lockdown see13).
As COVID-19 is thought to spread via contact between 
individuals through respiratory droplets,14 TRBs, such as 
physical distancing should be effective to reduce trans-
mission. Indeed, an early modelling study found that 
physical distancing measures can be effective in reducing 
the progression of the coronavirus that causes COVID-
19, delaying the epidemic peak, and delaying a potential 
secondary peak.15 In addition to direct social exposure to 
respiratory droplets, COVID-19 is also thought to spread 
by contact with infected surfaces and subsequently 
touching the eyes, nose or mouth.14 Since face- touching 
is frequent and habitual,16 prevention of transmission 
focuses on improving hand hygiene.17 Good hand 
hygiene means washing your hands frequently, using 
soap and water, and for at least 20 s.18 19 Hand washing 
is advised every time one enters a building, including 
entering one’s home, when you blow your nose, sneeze 
or cough, and eat or handle food.20 Hand washing 
has been shown to reduce the incidence of infectious 
diseases, especially when hand washing is done correctly 
and at the correct times.21–23
A study investigating public awareness of hand washing 
found that higher numbers of Google searches for ‘hand 
washing’ were associated with lower spreading speed of 
COVID-19 in 21 countries including England,24 suggested 
public interest in and adherence to effective hand 
washing practices might go hand in hand. In contrast, 
the evidence for the effectiveness of wearing facemasks 
or face coverings remains a topic of debate.25 26 WHO 
reiterated that there is limited evidence that wearing 
medical masks by the public is an effective preventive 
measure,27 28 but have recently changed their advice 
to recommend non- medical masks of face coverings in 
settings where physical distancing difficult.29 Wearing of 
a face covering (including nonmedical face coverings) 
in places where social distancing is difficult, such as food 
shops and public transport, has been advised worldwide, 
including recently at the start of Phase One after the 
lockdown in Scotland.30
It is not only necessary for the public to adopt these 
TRBs, it is also essential that they maintain adherence 
to TRBs consistently over the long term, certainly until 
a vaccine or other effective treatments for COVID-19 
become available. Prem et al,15 in their study of the effec-
tiveness of physical distancing, concluded that little is 
known about maintenance of the behaviour changes 
required of the population over time. Further, there are 
some easily identifiable challenges to the maintenance 
of TRBs. Hand washing is a highly habitual behaviour 
that is particularly resistant to sustained change,31 and 
the COVID-19 response required an increased frequency 
and probably thoroughness of hand washing for people 
in the general population. While some have argued that 
the precautionary principle be applied to the recommen-
dation to wear face coverings,25 32 others have cautioned 
against recommending their use without careful consider-
ation of their potential side effects,26 such as the potential 
to engender a false sense of security in relation to other 
TRBs, such as physical distancing and hand washing. This 
could result in reduced adherence to these TRBs that have 
demonstrated efficacy in relation to COVID-19 control.32 
In addition, to wear face coverings safely might necessi-
tate adoption of additional TRBs, such as not touching 
the masks, otherwise their use may be counterproduc-
tive.26 There is an important and urgent need, therefore, 
to understand adherence to TRBs over time. This need is 
especially pressing as lockdown restrictions are eased and 
adherence to TRBs, especially physical distancing, argu-
ably becomes more challenging.
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THEORETICAL APPROACHES TO HUMAN MOTIVATION AND 
BEHAVIOUR EXPLAINING TRB ADHERENCE
Three types of psychological theory are particularly perti-
nent to the situation of a pandemic and explaining how 
people behave when faced with an illness threat and with 
the requirement or advice to change their behaviour. 
First, models of how people think about the illness are 
important, second how people think about the recom-
mended behaviours and third how people think about 
the risks.
The common- sense model of self- regulation (CS- 
SRM) is a model of how an individual represents a 
potential illness threat, in this case COVID-19,33 and has 
for example previously been applied to predict psycho-
logical responses to Influenza A, H1N1.34 The CS- SRM 
identifies cognitive and emotional representations of 
illness and proposes that these representations affect 
the behavioural response to it. Cognitive representations 
that CS- SRM identifies are beliefs about illness identity 
(eg, label, symptoms), personal consequences of the 
illness, timeline including duration and fluctuations, 
whether and how the illness can be cured or controlled 
by the individual or by medical treatment and what causes 
the illness.35 Emotional representations indicate the 
emotions that are engendered by the illness threat (such 
as anxiety or worries). The person’s response, or way of 
coping with the threat, may be directed at the cognitive 
or emotional representations or at both: for example, 
they might engage in TRBs to reduce anxiety and/or 
to control exposure to the illness, but it is also possible 
that they might manage the emotional representation by 
avoiding thinking about the illness to avoid anxiety and 
so neglect to engage in TRBs.
Very few studies have looked at how illness represen-
tations change over time, as information about a disease 
spreads through a population, and experiences and 
government directives potentially change how the illness 
is represented.34 36 In the CS- SRM, behaviours are deter-
mined by illness representations, but TRBs may also be 
influenced by representations of the behaviours, for 
instance, the beliefs people have regarding their capa-
bility to adhere to the TRBs.
Social cognitive theory (SCT37) posits that people’s 
motivation and action are extensively regulated by fore-
thought about the behaviour.38 Key constructs of SCT 
are self- efficacy and outcome expectancies. Self- efficacy 
refers to the belief that one is capable of performing a 
recommended behaviour to attain a desired outcome (ie, 
not getting COVID-19). Outcome expectancies refer to 
beliefs about the consequences of a given behaviour (eg, 
if I wash my hands regularly with soap and water, I will 
reduce my risk of getting COVID-19). A category of belief 
that is often explored in relation to infectious disease 
outbreaks, but that is not specified explicitly in SCT, is 
risk perception, or perceived vulnerability to the infec-
tious disease.39
Protection motivation theory (PMT40 41) was developed 
to understand the impact of fear appeals and includes the 
perception of vulnerability. PMT posits that people make 
a threat appraisal based on evaluating how severe the 
threat is, and how vulnerable they perceive themselves 
to be to the threat. In addition, an individual makes a 
coping appraisal based on two efficacy beliefs, self- efficacy 
(as in SCT, eg, how confident is the person that they can 
wash their hands every time they enter a building) and 
response efficacy (how effective is washing hands every 
time they enter a building at mitigating vulnerability to 
getting COVID-19). Considering both the threat and 
coping appraisal could result in greater understanding 
of the engagement in protective behaviours, in this case 
adherence to TRBs.39
Given the importance of motivational and behavioural 
factors to get COVID-19 under control, it is vitally 
important to determine how these theorised factors are 
linked to adherence to TRBs and how this affects mental 
and general health. Previous research has shown that 
greater perceived susceptibility, perceived severity of 
the illness as well as, perceived efficacy of behaviour and 
self- efficacy of TRBs during previous infectious disease 
pandemics were associated with more avoidance (ie, 
physical distancing) or preventive behaviour (ie, hand 
washing).42 Furthermore, during the current COVID-19 
pandemic in Vietnam, perceived risk was associated with 
increased likelihood of wearing a face covering.43 Multiple 
theoretical positions applied to TRBs, and measured 
over repeated epochs, should provide novel insights into 
behavioural changes emerging from the population in 
Scotland.
THE CHARIS STUDY AND OBJECTIVES
The majority of other surveys about COVID-19, including 
the large international surveys, collect data from self- 
selecting participants who complete the survey online; 
they are not random samples of a population. The 
representativeness of that sample is assessed relative to 
selected nationally representative socio- demographic 
characteristics and the sample adjusted so that it matches 
those characteristics. In contrast, the participants in the 
CHARIS study will be selected randomly and interviewed 
until predefined quotas for particular sociodemographic 
characteristics are met. The interviews will be conducted 
over the telephone, so participants do not require the 
financial resources or any computer literacy to take part 
or have any predisposition to complete an online survey 
about the pandemic. This will ensured that we have a 
nationally representative sample. Further, to our knowl-
edge, ours is the only survey that employs three distinct 
theoretical approaches to understanding adherence of 
eight key TRBs.
The aim of the CHARIS study is to investigate adher-
ence to TRBs required and advised by The Scottish 
Government and how adherence changes over time, as 
postlockdown restrictions are lifted across four graduated 
Phases.13 CHARIS will examine what theorised motiva-
tional and behavioural factors explain (changes in) TRB 
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adherence, and mental and general health over time. 
The following objectives will be addressed:
1. To describe people’s adherence to TRBs, and their 
mental and general health status.
2. To describe people’s beliefs about COVID-19 and be-
liefs about TRBs.
3. To explain variations in people’s adherence to TRBs by 
examining associations between these behaviours and 
sociodemographic factors, and theorised motivational 
and behavioural factors, specifically considering,
4. To explain variations in people’s mental and general 
health status by examining associations between health 
and sociodemographic and theorised motivational and 
behavioural factors.
5. To examine the influence of government guidance 
and media reporting of COVID-19 on people’s beliefs 
and behaviours over time.
METHODS
Design
A cross- sectional observational study of 500 randomly 
selected adults will be conducted each week for the first 
6 weeks, and fortnightly after that, for a total of 14 waves 
(n=7000). We will compare motivations, behaviours and 
health in different population groups (eg, age group, 
gender, area deprivation) and use these data to under-
stand population- level changes in adherence to TRBs 
and health from 3 June 2020 and to 07 November 2020. 
While a serial cross- sectional design will not allow for the 
assessment of actual causal relations over time it does 
allow rapid and adaptive monitoring of crucial variables 
over time, the assessment of the relations between them 
and, importantly, since there is no attrition, maintains 
the representativeness of the sample over the whole study 
period.
Setting and participants
The study will be conducted across Scotland which has a 
total population of 5.4 million, 83% of whom are adults. 
Adult men and women aged 16 or older, able to speak 
English, and currently living in Scotland are eligible to 
participate. No other inclusion criteria will be applied. 
The CHARIS study will be administered by a commercial 
polling company (Ipsos MORI Scotland). They sample 
participants using random digit dialling to both landlines 
and targeted mobiles. Quotas are applied to ensure that 
a representative sample of Scotland adults is achieved. 
Quotas are based on gender (48% male), age, working 
status (42% working fulltime) and geographical locations 
(distribution over the Scottish Parliament regions). A 
leeway on the quotas (30% approximately) is allowed to 
help ensure the overall sample is achieved in a reasonable 
time, any resulting data skews will be corrected with statis-
tical weighting in analyses.
Sample size for assessing the proportion of people who 
adhere to government guidelines was determined by the 
following formula for the sample size n: n=N*X / (X+N 
– 1), where, X=Zα/22  *p*(1 p) / MOE2, and Zα/2 is the 
critical value of the Normal distribution at α/2 (we used 
a confidence level of 95%, α is 0.05 and the critical value 
is 1.96), MOE is the margin of error (we used 5%), p is 
the sample proportion (as we did not know adherence 
beforehand this was set at 50%), and N is the population 
size (5 438 100 for the adult Scottish population). This 
returns a sample size of n=385. In addition, we wanted 
to be able to look at subgroups and evidence over time, 
based on these calculations and advise from the polling 
station on the number required to reach a representative 
sample for the Scottish population in each data wave was 
determined at n=500.
Ipsos MORI will conduct telephone interviews using 
Computer Aided Telephone Interviewing (CATI). Inter-
viewers from Ipsos MORI have received training and 
have significant experience in conducting interviews into 
sensitive topics including mental and general health.
Patient and public involvement statement
During the design of the study and the development 
of the questionnaire, we engaged with two patient and 
public involvement groups. The Scottish Health Council 
Public Engagement Group and the National Health 
Service (NHS) Research Scotland Primary Care Patient 
and Public Involvement group. They have explored the 
suggested topic the questionnaire was going to include, 
and have reviewed and critiqued the survey questions and 
suggested items. This led to the addition of more ques-
tions about physical or mental health conditions, and 
their effect on day- to- day activities. Additionally, the two 
patient and public involvement groups in addition to the 
core research group and members of the consortium were 
welcome to suggest topic to be assessed in the non- core 
part of the questionnaire. The core research group will 
make the final decision on all proposed inclusions. People 
from the patient or public involvement groups were not 
directly involved in the recruitment to and conduct of the 
study, but could be recruited through the random digit 
dialling procedure. All study participants had access to 
the weekly published reports on the CHARIS website.
Questionnaire development and procedure
Using methods from studies of previous pandemics (eg, 
SARS, Middle East Respiratory Syndrome or MERS, 
H1N1) and theories of human motivation and behaviour, 
the survey will assess adherence to TRBs, and mental 
and general health. Where possible, validated and reli-
able scales will be used. However, some of the standard 
measurement scales have been adapted to fit with the 
CATI methodology.
A core set of questions will be administered weekly 
(further details on questionnaire development online 
supplemental appendix 1). In addition, each week a 
changing set of questions will assess non- core themes and 
questions based on triggers/events over time as required 
(up to 15% of the total questionnaire is available for modi-
fication each week). The additional themes and questions 
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will be sent to Ipsos MORI 4 days in advance for review, 
scripting and testing. Weekly, Ipsos MORI takes 3 days for 
data processing and will provide the primary researchers 
with a raw data set for analysis (Statistical plan in online 
supplemental appendix 2).
Core survey variables
The questions of the wave one questionnaire, including the 
core survey are detailed in online supplemental appendix 
3.
Transmission-reducing behaviours
Adherence for TRBs will be assessed for three domains 
of behaviours, namely physical distancing, hand washing 
and wearing a face coverings, based on Scottish Govern-
ment directives and NHS Scotland advice.20 44 TRBs 
will be assessed using eight items.45 46 Questions will be 
preceded by an introductory text, which aims to reduce 
socially desirable responding by providing individuals 
with implied permission to report either a lack of, or 
lapses in, adherence.
Mental and general health
We will measure general health by a standard single self- 
report item.47 Depression and anxiety will be assessed 
with an adaption of the brief anxiety and depression scale 
(Patient Health Questionnaire-448). Finally, participants 
will be asked whether they received a letter from their 
general practitioner telling them that they were at high 
risk and should stay at home. If they answered ‘Yes’, they 
will be asked whether they have been in isolation because 
they have been shielding.
Theorised motivational and behavioural explanatory factors
The guiding theoretical frameworks for understanding 
COVID-19 will be Leventhal’s CS- SRM49, SCT37 and 
PMT40. We have adapted the brief illness perception ques-
tionnaire50 for COVID-19. The brief illness perception 
questionnaire uses a single statement to assess each of 
the constructs from the CS- SRM, namely: identity, conse-
quences, duration (time- line), recurrence (time- line), 
personal control, treatment control and emotional repre-
sentation (worried and anxious); participants indicate 
their level of agreement with each statement. Questions 
are differently phrased for participants who currently 
have (or suspect they have) COVID-19, who have had (or 
suspect they have had) COVID-19 in the past. The causal 
component of the COVID-19 representation is assessed 
with seven items; participants indicate the extent to which 
they believe each item is/was/would likely be the cause of 
their getting COVID-19 using a 4- point scale (1=to a great 
extent, 4=not at all).
We will assess outcome expectancies, self- efficacy 
(towards the avoidance of COVID-19 and performing 
the TRBs51), perceived COVID-19 severity, perceived 
vulnerability, comparative vulnerability, response efficacy, 
behavioural norms and intentions to perform the TRBs 
(adapted from references 52 53).
Sociodemographic variables
Sociodemographic information included in the core survey 
are; place of residence and area deprivation (based on post-
code), age, indicated gender, ethnicity, number of adults and 
children living in people’s household, household tenure and 
employment status.47
Additional variables
In addition to the measures of the core, the survey will also 
include measures of additional factors that are likely to 
predict one or both of the outcome variables; adherence to 
TRBs and mental and general health (online supplemental 
appendix 1). These variables can also be related to changes 
in government guidelines and event- related questions.
ETHICS AND DISSEMINATION
Participants will be informed about the purpose of the 
CHARIS study, how their data will be treated and stored, of 
their right to terminate their participation in the study at any 
time without giving a reason, and for each question where 
we are asking personal/sensitive information participants 
will explicitly be reminded that they do not have to answer 
if they prefer not to. All participants will then be asked to 
provide verbal informed consent prior to starting the survey, 
and for sharing their personal information for follow- up 
research related to the study (online supplemental appendix 
2). Verbal debriefing will inform participants that if the 
survey has raised any concerns about their health that, they 
should contact their general practitioner. Ethical approval 
was granted by the Life Sciences and Medicine College 
Ethics Review Board (CERB) at the University of Aberdeen 
(CERB/2020/5/1942).
This study aims to have academic and conceptual devel-
opment impact by making a demonstrable contribution to 
understanding theorised human motivations and behaviours, 
adherence to TRBs, and mental and general health in a 
global pandemic. Key outputs will therefore include articles 
for publication in peer- review journals.
More importantly, the study also aims to have societal 
and instrumental impact by influencing the measures used 
to reduce COVID-19 transmissions and monitor measures 
that address impacts on mental and general health that are 
being developed by UK governments and other decision- 
makers. Key outputs are, therefore, weekly bulletins that 
describe the data and present univariate analyses that will 
provide fast, real- time insights. These weekly bulletins will 
be complemented with bimonthly in- depth reports that will 
present the multivariate predictive data, and illustrate how 
the results might be used to support adherence and mental 
and general health. The bulletins and reports will be distrib-
uted to the Scottish Government and their agencies, and will 
be made immediately available on the study website (https://
www. abdn. ac. uk/ CHARIS), and study’s own twitter feed (@
CHARIS CVD19).
DISCUSSION
The CHARIS study will provide insights into TRBs, and how 
adherence to these TRBs changes over time as the COVID-19 
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outbreak progresses, and government restrictions are change. 
Additionally, this study will identify the beliefs derived from 
CS- SRM, SCT and PMT, and sociodemographic factors that 
predict adherence to TRBs. This understanding will support 
the tailoring and targeting of interventions to improve adher-
ence to TRBs, and support general and mental health. For 
example, the content of public health messages could be 
tailored to strengthen beliefs associated with higher levels 
of adherence, and targeted at communities who are strug-
gling to adhere. Similarly, CHARIS will identify communities 
with declining mental health enabling support services to be 
better targeted.
Strengths
The CHARIS study has several strengths. First, CHARIS is 
underpinned by evidence- based psychological theories and 
thus supports a cumulative approach to conceptual devel-
opment and evidence. CHARIS can draw on a large existing 
evidence base that informs the measures used, and details how 
individual constructs are meaningfully related. Use of three 
universal theories of behaviour avoids the much criticised 
‘cafeteria’ style research that is not conducive to the devel-
opment of a cumulative approach to evidence building.54 55 
A cumulative approach is vital to support our understanding 
of the behaviour of populations during a pandemic, which 
is crucial in circumstances where changing behaviour is the 
only available route to halting the pandemic.
Second, CHARIS will provide fast, real time, information 
to support and inform decision making for policy- makers, 
public health and service commissioners. Third, the weekly 
data collection, enables fine- grained analyses of people’s reac-
tions to government directives and instructions as they are 
happening. The repeated measurement over 14 waves makes 
it possible to directly assess the impact of directives and advice 
from the government for TRBs, in contrast to previous retro-
spective studies or studies applying hypothetical situations.56 
Fourth, our study will start as the Government- imposed 
restrictions went in to phase 1 postlockdown. The restrictions 
began to be eased, and more people are allowed to go back 
to their workplaces, and to start to meet with others outside 
of their own households. The timing of the CHARIS study 
places it in the unique position to assess (changing) adher-
ence to TRBs, in response to potentially changing beliefs 
about the behaviours and the illness, as the Scottish govern-
ment implements new Phases to gradually lift the restrictions. 
Moreover, we can assess the effects of prolonged adherence 
to TRBs, and beliefs about behaviours and illness on mental 
and general health. Fifth, CHARIS study data is collected via 
telephone, which requires the survey to be succinct and the 
questions easily understood. Therefore, the majority of adults 
will be able to take part in CHARIS, in line with the call that 
there is a need for more representative research, particularly 
in vulnerable populations.57 58 People can be included who 
do not have online access, who are typically older, who are 
more deprived, typically those who are also most at risk from 
COVID-19. Sixth, recruitment will aim for a representative 
sample, making the findings generalisable to the Scottish 
population.
Limitations
Our study also has some limitations. First, the use of a tele-
phone survey necessitates the use of self- report measures 
only. This is not a limitation in relation to the measure-
ment of beliefs or mental and general perceived health as 
these are only available for measurement via self- report. 
However, measuring behaviour by self- report is open to a 
number of sources of error, including memory errors and 
social desirability bias. Social desirability to report adher-
ence is likely, however, we have mitigated the impact of 
social desirability where possible by employing the intro-
ductory text from the medication adherence reporting 
scale.45 46 The text on this scale was designed specifically 
to reduce social desirability by providing individuals with 
implied permission to report either a lack of, or lapses in, 
adherence. Furthermore, it is impossible to assess adher-
ence to all the TRBs included in CHARIS by any method 
other than by self- report. Overall, we believe the advan-
tages of telephone interviewing in terms of population 
reach and generalisability far outweigh the disadvantages.
Second, the telephone call is limited to 20 min dura-
tion. This means we have had to be use brief measures of 
mental and general health, however, both measures are 
validated and reliable. Similarly, some constructs were 
measured very briefly in the core questionnaire. While 
this enables tracking of a larger number of themes over 
time, we recognised this as a limitation. To address the use 
of brief measures we have planned less frequent inclusion 
of some constructs, for example, access to open spaces is 
measured with one question in the core questionnaire, 
focused only on the home, but will be measured much 
more extensively during one specified week to provide a 
context for the single question in the core questionnaire, 
and provide an opportunity to have in- depth analysis of 
this theme with the data collected in one of the weeks. 
Moreover, some themes were not part of the core at all, 
and only will only be assessed less frequently. In addition, 
we plan a companion qualitative study that will purpo-
sively sample from the survey participants each week to 
understand the contextualised, multifaceted nature of 
people’s beliefs, TRBs and mental and general health.
The CHARIS Study is well placed to make a significant 
contribution to the knowledge base around (changes in) 
adherence to TRBs, mental health and potential explan-
atory variables, in the current COVID-19 pandemic. 
Further, findings should provide valuable insights to assist 
preparation for any future events.
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